Published in J Inflamm (Lond) on March 16, 2009
Obesity, inflammation, and liver cancer. J Hepatol (2011) 2.09
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol (2013) 1.49
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol (2010) 1.35
Prediabetes and prehypertension in disease free obese adults correlate with an exacerbated systemic proinflammatory milieu. J Inflamm (Lond) (2010) 1.10
Is Assessing the Presence of NASH by Liver Histology or Surrogate Markers Always Advisable? Hepat Mon (2013) 0.94
Liver-spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol (2013) 0.92
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. J Transl Med (2011) 0.91
Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease. Am J Pathol (2012) 0.90
Relationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents. Nutr J (2011) 0.89
Waist circumference as the predominant contributor to the micro-inflammatory response in the metabolic syndrome: a cross sectional study. J Inflamm (Lond) (2010) 0.88
Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from NAFLD, with normal or slightly increased liver enzymes. Oxid Med Cell Longev (2014) 0.87
Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. World J Gastroenterol (2013) 0.87
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Hepatic steatosis in overweight/obese females: new screening method for those at risk. World J Gastroenterol (2009) 0.84
Serum 25-Hydroxyvitamin D Levels, phosphoprotein enriched in diabetes gene product (PED/PEA-15) and leptin-to-adiponectin ratio in women with PCOS. Nutr Metab (Lond) (2011) 0.82
Inflammation-induced atherosclerosis as a target for prevention of cardiovascular diseases from early life. Open Cardiovasc Med J (2010) 0.82
Non-alcoholic fatty liver disease, diet and gut microbiota. EXCLI J (2014) 0.81
Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease. PLoS One (2014) 0.81
Central obesity and nonalcoholic fatty liver disease risk after adjusting for body mass index. World J Gastroenterol (2015) 0.79
Chemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agents. World J Gastroenterol (2016) 0.77
Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation. World J Gastroenterol (2015) 0.77
Chronic sub-clinical inflammation in the abdominal adipose tissue - Evaluation of inflammatory cytokines and their link with insulin resistance in metabolically obese South Indians: A cross-sectional observational study. Indian J Endocrinol Metab (2016) 0.77
Emotion-Based Cognition in Mice Is Differentially Influenced by Dose and Chemical Form of Dietary Docosahexaenoic Acid. Nutrients (2017) 0.75
Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 109.13
Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med (1999) 16.57
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest (2008) 6.60
Identification and characterization of metabolically benign obesity in humans. Arch Intern Med (2008) 5.74
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis (2006) 2.83
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology (2008) 2.70
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH. J Gastroenterol (2007) 2.29
Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes (2006) 1.75
Effect of 6-month calorie restriction and exercise on serum and liver lipids and markers of liver function. Obesity (Silver Spring) (2008) 1.64
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol (2007) 1.60
Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol (2009) 1.50
Determinants of insulin-resistant phenotypes in normal-weight and obese Black African women. Obesity (Silver Spring) (2008) 1.31
Insulin sensitivity is correlated with subcutaneous but not visceral body fat in overweight and obese prepubertal children. J Clin Endocrinol Metab (2008) 1.25
Sonographic assessment of regional adiposity. AJR Am J Roentgenol (2007) 1.12
Non-invasive quantification of hepatic fat fraction by fast 1.0, 1.5 and 3.0 T MR imaging. Eur J Radiol (2007) 1.12
Association between low thigh fat and non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2008) 1.06
Do inflammation and procoagulation biomarkers contribute to the metabolic syndrome cluster? Nutr Metab (Lond) (2007) 1.02
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. Ann Nutr Metab (2005) 0.97
Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean healthy adults. Metabolism (2008) 0.94
Comparison of ultrasonographic and anthropometric methods to assess body fat in childhood obesity. Int J Obes (Lond) (2006) 0.90
Sonography detection of small intra-abdominal fat variations. Int J Obes (1991) 0.90
Distribution of subcutaneous fat predicts insulin action in obesity in sex-specific manner. Obesity (Silver Spring) (2008) 0.89
Ultrasonography for the evaluation of visceral fat and the metabolic syndrome. Metabolism (2005) 0.88
Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy. Liver Int (2008) 0.87
Sonographic assessment of changes in thickness of different abdominal fat layers in response to diet in obese women. J Clin Ultrasound (2003) 0.81
III Brazilian Thoracic Association Guidelines on tuberculosis. J Bras Pneumol (2009) 2.64
Prevention and treatment of implanted central venous catheter (CVC) - related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr (2002) 2.15
Early psoriatic arthritis: the clinical spectrum. J Rheumatol (2007) 1.79
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. J Gastroenterol Hepatol (2007) 1.60
Systemic sclerosis-associated interstitial pneumonia: evaluation of pulmonary function over a five-year period. J Bras Pneumol (2011) 1.52
Could inflammatory markers help diagnose nonalcoholic steatohepatitis? Eur J Gastroenterol Hepatol (2009) 1.50
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? World J Gastroenterol (2013) 1.49
Central venous catheter infections and antibiotic therapy during long-term home parenteral nutrition: an 11-year follow-up study. JPEN J Parenter Enteral Nutr (2010) 1.45
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? BMC Gastroenterol (2009) 1.24
Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18
Silent non-alcoholic fatty liver disease-a clinical-histological study. J Hepatol (2004) 1.15
Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign? J Transl Med (2008) 1.14
Are hepatic steatosis and carotid intima media thickness associated in obese patients with normal or slightly elevated gamma-glutamyl-transferase? J Transl Med (2012) 1.10
Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr (2010) 1.09
Severe acute liver damage in anorexia nervosa: two case reports. Nutrition (2006) 1.07
Treatment of hemophilia: a review of current advances and ongoing issues. J Blood Med (2010) 1.07
Nutritional screening and early treatment of malnutrition in cancer patients. J Cachexia Sarcopenia Muscle (2011) 1.05
High leptin/adiponectin ratio and serum triglycerides are associated with an "at-risk" phenotype in young severely obese patients. Obesity (Silver Spring) (2010) 1.04
Nail and distal interphalangeal joint in psoriatic arthritis. J Rheumatol (2006) 1.00
Bariatric surgery and diabetes remission: sleeve gastrectomy or mini-gastric bypass? World J Gastroenterol (2013) 1.00
Metabolic factors involved in the therapeutic response of patients with hepatitis C virus-related chronic hepatitis. J Gastroenterol Hepatol (2006) 1.00
Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle (2012) 1.00
Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. World J Gastroenterol (2009) 0.98
Disseminated intravascular coagulation in hematologic malignancies. Semin Thromb Hemost (2010) 0.98
Predictors of early minimal disease activity in patients with psoriatic arthritis treated with tumor necrosis factor-α blockers. J Rheumatol (2012) 0.98
Obesity and psoriatic arthritis: from pathogenesis to clinical outcome and management. Rheumatology (Oxford) (2012) 0.96
Paracoccidioidomycosis: high-resolution computed tomography-pathologic correlation. Eur J Radiol (2009) 0.96
Fasting respiratory quotient as a predictor of long-term weight changes in non-obese women. Ann Nutr Metab (2004) 0.96
A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. Hepatol Res (2007) 0.96
Prognostic significance of bioelectrical impedance phase angle in advanced cancer: preliminary observations. Nutrition (2009) 0.96
Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease. Future Microbiol (2015) 0.95
The effectiveness of a traditional therapeutical approach in early psoriatic arthritis: results of a pilot randomised 6-month trial with methotrexate. Clin Rheumatol (2007) 0.94
Predictive factors of survival in patients with peritoneal carcinomatosis on home parenteral nutrition. Nutrition (2006) 0.92
Liver-spleen axis: intersection between immunity, infections and metabolism. World J Gastroenterol (2013) 0.92
Effects of treatment with metformin on TSH levels: a meta-analysis of literature studies. J Clin Endocrinol Metab (2013) 0.91
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. Semin Thromb Hemost (2011) 0.91
Body composition changes after weight-loss interventions for overweight and obesity. Clin Nutr (2012) 0.90
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery. Cochrane Database Syst Rev (2015) 0.90
Filling the gap between science & clinical practice: prevention of stroke recurrence. Thromb Res (2011) 0.90
Troponin I and right ventricular dysfunction for risk assessment in patients with nonmassive pulmonary embolism in the Emergency Department in combination with clinically based risk score. Intern Emerg Med (2008) 0.90
The infectious burden in atherothrombosis. Semin Thromb Hemost (2012) 0.90
Hepatic steatosis, carotid plaques and achieving MDA in psoriatic arthritis patients starting TNF-α blockers treatment: a prospective study. Arthritis Res Ther (2012) 0.90
Tissue factor and atherosclerosis: not only vessel wall-derived TF, but also platelet-associated TF. Thromb Res (2011) 0.90
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease. World J Gastroenterol (2011) 0.89
High-resolution computed tomography in silicosis: correlation with chest radiography and pulmonary function tests. J Bras Pneumol (2008) 0.89
Computed tomography findings of pneumatosis and portomesenteric venous gas in acute bowel ischemia. World J Gastroenterol (2013) 0.89
Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study. Am J Hematol (2012) 0.89
BMR variability in women of different weight. Clin Nutr (2007) 0.89
Wernicke encephalopathy in subjects undergoing restrictive weight loss surgery: a systematic review of literature data. Eur Eat Disord Rev (2014) 0.88
Inhibition of the mTOR pathway: a possible protective role in coronary artery disease. Ann Med (2013) 0.88
Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol (2013) 0.87
Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. Clin Invest Med (2008) 0.87
Neuroprotective, immunosuppressant and antineoplastic properties of mTOR inhibitors: current and emerging therapeutic options. Curr Opin Pharmacol (2011) 0.87
Spleen: A new role for an old player? World J Gastroenterol (2011) 0.87
Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms. World J Gastroenterol (2006) 0.87
Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease. World J Gastroenterol (2013) 0.87
Safety and efficacy of barbed suture for gastrointestinal suture: a prospective and randomized study on obese patients undergoing gastric bypass. J Laparoendosc Adv Surg Tech A (2013) 0.87
Relation of flow-mediated dilation to global arterial load: impact of hypertension and additional cardiovascular risk factors. Int J Cardiol (2010) 0.86
Noninvasive evaluation of abdominal fat and liver changes following progressive weight loss in severely obese patients treated with laparoscopic gastric bypass. Obes Surg (2009) 0.86
Reliability of total overnight salivary caffeine assessment (TOSCA) for liver function evaluation in compensated cirrhotic patients. Eur J Clin Pharmacol (2006) 0.86
Six novel mutations in the proopiomelanocortin and melanocortin receptor 4 genes in severely obese adults living in southern Italy. Clin Chem (2005) 0.86
Is serum Interleukin-17 associated with early atherosclerosis in obese patients? J Transl Med (2014) 0.86
Oxidative stress and nitric oxide pathway in adult patients who are candidates for cardiac surgery: patterns and differences. Interact Cardiovasc Thorac Surg (2013) 0.86
What does irritable bowel syndrome share with non-alcoholic fatty liver disease? World J Gastroenterol (2013) 0.85
Pharmacokinetic interaction between levofloxacin and ciclosporin or tacrolimus in kidney transplant recipients: ciclosporin, tacrolimus and levofloxacin in renal transplantation. Clin Pharmacokinet (2006) 0.85
Relative fat-free mass deficiency and left ventricular adaptation to obesity: the Strong Heart Study. Int J Cardiol (2012) 0.85
Metabolic and nutritional status changes after 10% weight loss in severely obese patients treated with laparoscopic surgery vs integrated medical treatment. Obes Surg (2007) 0.85
Exposure to ambient air particulate matter and non-alcoholic fatty liver disease. World J Gastroenterol (2013) 0.85
Diffuse idiopathic skeletal hyperostosis prevalence in subjects with severe atherosclerotic cardiovascular diseases. Arthritis Care Res (Hoboken) (2012) 0.85
Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies. Clin Rheumatol (2013) 0.85
Diets naturally rich in polyphenols improve fasting and postprandial dyslipidemia and reduce oxidative stress: a randomized controlled trial. Am J Clin Nutr (2013) 0.84
Rhodococcus equi infection in acquired immunodeficiency syndrome. Computed tomography aspects. J Bras Pneumol (2007) 0.84
Hepatic steatosis in overweight/obese females: new screening method for those at risk. World J Gastroenterol (2009) 0.84
Functional analysis of melanocortin-4-receptor mutants identified in severely obese subjects living in Southern Italy. Gene (2010) 0.83
Severity classification for idiopathic pulmonary fibrosis by using fuzzy logic. Clinics (Sao Paulo) (2011) 0.83
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. Clin Invest Med (2007) 0.83
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature. Intern Emerg Med (2015) 0.82
Prevalence of thyroid autoimmunity in patients with spondyloarthropathies. J Rheumatol (2011) 0.82